Literature DB >> 8206511

The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.

J Poudrier1, T Owens.   

Abstract

The mechanism whereby small resting (high buoyant density) murine B cells are induced to express interleukin-2 receptors (IL-2R) and to respond to IL-2 was addressed by staining with anti-IL-2R alpha and -IL-2R beta monoclonal antibodies (mAb), and using receptor-specific cDNA probes. Resting B cells expressed undetectable levels of both IL-2R alpha and beta chains on their surface and did not respond to IL-2, even at supra-physiological concentrations. Sepharose-coupled, but not streptavidin-cross-linked, plastic-adsorbed or soluble, anti-mu up-regulated the expression of IL-2R alpha and beta chains and mRNA to levels comparable to those seen in activated T cells. Anti-mu-stimulated B cells responded to IL-2 by incorporation of [3H]thymidine and high rate immunoglobulin (Ig) secretion. Both IL-5 (at optimal concentration) and suboptimal lipopolysaccharide (LPS; 20 ng/ml) induced surface expression of IL-2R alpha. The level of expression induced by IL-5 was equivalent to that on anti-Ig-activated B cells. Neither stimulus induced detectable expression of IL-2R beta, and neither induced B cells to respond to IL-2. IL-2R alpha expression was strongly enhanced, and low levels of IL-2R beta staining and mRNA were induced by the combination of LPS plus IL-5. LPS+IL-5-treated B cells responded to IL-2 by Ig secretion. This indicates that B cells regulate their responsiveness to IL-2 similarly to T cells, via the combined level of expression of IL-2R beta and IL-2R alpha. The synergy between IL-5 and LPS for B-cell responses shows a requirement for complementary stimuli such as would be provided by cytokines, and either cellular interaction or antigen recognition in regulation of B-cell responsiveness to IL-2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206511      PMCID: PMC1422333     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells.

Authors:  T Nakagawa; T Hirano; N Nakagawa; K Yoshizaki; T Kishimoto
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

Review 2.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets.

Authors:  P Lake; E A Clark; M Khorshidi; G H Sunshine
Journal:  Eur J Immunol       Date:  1979-11       Impact factor: 5.532

4.  Activation of antigen-specific B cells: role of T cells, cytokines, and antigen in induction of growth and differentiation.

Authors:  R J Noelle; E C Snow; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

5.  Dissociation of two signals required for activation of resting B cells.

Authors:  M H Julius; H von Boehmer; C L Sidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells.

Authors:  A W Boyd; B L Pike
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

7.  Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA.

Authors:  A J Minty; M Caravatti; B Robert; A Cohen; P Daubas; A Weydert; F Gros; M E Buckingham
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

8.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

Authors:  T R Malek; R J Robb; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells.

Authors:  R Ceredig; J W Lowenthal; M Nabholz; H R MacDonald
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  2 in total

1.  Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.

Authors:  Bruce M Hall; Rachael M Hall; Giang T Tran; Catherine M Robinson; Paul L Wilcox; Prateek K Rakesh; Chuanmin Wang; Alexandra F Sharland; Nirupama D Verma; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

2.  CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation.

Authors:  J Poudrier; T Owens
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.